396 related articles for article (PubMed ID: 19854140)
1. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.
Choudhary C; Olsen JV; Brandts C; Cox J; Reddy PN; Böhmer FD; Gerke V; Schmidt-Arras DE; Berdel WE; Müller-Tidow C; Mann M; Serve H
Mol Cell; 2009 Oct; 36(2):326-39. PubMed ID: 19854140
[TBL] [Abstract][Full Text] [Related]
2. Abnormal localization and accumulation of FLT3-ITD, a mutant receptor tyrosine kinase involved in leukemogenesis.
Koch S; Jacobi A; Ryser M; Ehninger G; Thiede C
Cells Tissues Organs; 2008; 188(1-2):225-35. PubMed ID: 18303245
[TBL] [Abstract][Full Text] [Related]
3. Constitutively activated FLT3 phosphorylates BAD partially through pim-1.
Kim KT; Levis M; Small D
Br J Haematol; 2006 Sep; 134(5):500-9. PubMed ID: 16869825
[TBL] [Abstract][Full Text] [Related]
4. Transformation by oncogenic mutants and ligand-dependent activation of FLT3 wild-type requires the tyrosine residues 589 and 591.
Vempati S; Reindl C; Wolf U; Kern R; Petropoulos K; Naidu VM; Buske C; Hiddemann W; Kohl TM; Spiekermann K
Clin Cancer Res; 2008 Jul; 14(14):4437-45. PubMed ID: 18628457
[TBL] [Abstract][Full Text] [Related]
5. The juxtamembrane domain in ETV6/FLT3 is critical for PIM-1 up-regulation and cell proliferation.
Vu HA; Xinh PT; Kano Y; Tokunaga K; Sato Y
Biochem Biophys Res Commun; 2009 Jun; 383(3):308-13. PubMed ID: 19345670
[TBL] [Abstract][Full Text] [Related]
6. A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival.
Masson K; Liu T; Khan R; Sun J; Rönnstrand L
Br J Haematol; 2009 Jul; 146(2):193-202. PubMed ID: 19438505
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases.
Schmidt-Arras DE; Böhmer A; Markova B; Choudhary C; Serve H; Böhmer FD
Mol Cell Biol; 2005 May; 25(9):3690-703. PubMed ID: 15831474
[TBL] [Abstract][Full Text] [Related]
8. Pim-1 kinase phosphorylates and stabilizes 130 kDa FLT3 and promotes aberrant STAT5 signaling in acute myeloid leukemia with FLT3 internal tandem duplication.
Natarajan K; Xie Y; Burcu M; Linn DE; Qiu Y; Baer MR
PLoS One; 2013; 8(9):e74653. PubMed ID: 24040307
[TBL] [Abstract][Full Text] [Related]
9. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways.
Yan GR; Xiao CL; He GW; Yin XF; Chen NP; Cao Y; He QY
Proteomics; 2010 Mar; 10(5):976-86. PubMed ID: 20049867
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD.
Kazi JU; Chougule RA; Li T; Su X; Moharram SA; Rupar K; Marhäll A; Gazi M; Sun J; Zhao H; Rönnstrand L
Cell Mol Life Sci; 2017 Jul; 74(14):2679-2688. PubMed ID: 28271164
[TBL] [Abstract][Full Text] [Related]
11. Actors of the tyrosine kinase receptor downstream signaling pathways in amphioxus.
Bertrand S; Campo-Paysaa F; Camasses A; García-Fernàndez J; Escrivà H
Evol Dev; 2009; 11(1):13-26. PubMed ID: 19196330
[TBL] [Abstract][Full Text] [Related]
12. Targeting receptor tyrosine kinase signaling in acute myeloid leukemia.
Doepfner KT; Boller D; Arcaro A
Crit Rev Oncol Hematol; 2007 Sep; 63(3):215-30. PubMed ID: 17658267
[TBL] [Abstract][Full Text] [Related]
13. Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality.
Schmidt-Arras D; Böhmer SA; Koch S; Müller JP; Blei L; Cornils H; Bauer R; Korasikha S; Thiede C; Böhmer FD
Blood; 2009 Apr; 113(15):3568-76. PubMed ID: 19204327
[TBL] [Abstract][Full Text] [Related]
14. [Signal transduction by protein tyrosine kinases and antitumor agents].
Mao YJ; Li HH; Li JF; Shen JS
Yao Xue Xue Bao; 2008 Apr; 43(4):323-34. PubMed ID: 18664191
[TBL] [Abstract][Full Text] [Related]
15. A phosphoproteomics approach to elucidate neuropeptide signal transduction controlling insect metamorphosis.
Rewitz KF; Larsen MR; Lobner-Olesen A; Rybczynski R; O'Connor MB; Gilbert LI
Insect Biochem Mol Biol; 2009 Jul; 39(7):475-83. PubMed ID: 19422916
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis.
Porter AC; Vaillancourt RR
Oncogene; 1998 Sep; 17(11 Reviews):1343-52. PubMed ID: 9779982
[TBL] [Abstract][Full Text] [Related]
17. Receptor tyrosine kinase signaling: a view from quantitative proteomics.
Dengjel J; Kratchmarova I; Blagoev B
Mol Biosyst; 2009 Oct; 5(10):1112-21. PubMed ID: 19756300
[TBL] [Abstract][Full Text] [Related]
18. Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT.
Brahimi-Adouane S; Bachet JB; Tabone-Eglinger S; Subra F; Capron C; Blay JY; Emile JF
Mol Oncol; 2013 Jun; 7(3):323-33. PubMed ID: 23146721
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis.
Chatterjee A; Ghosh J; Ramdas B; Mali RS; Martin H; Kobayashi M; Vemula S; Canela VH; Waskow ER; Visconte V; Tiu RV; Smith CC; Shah N; Bunting KD; Boswell HS; Liu Y; Chan RJ; Kapur R
Cell Rep; 2014 Nov; 9(4):1333-48. PubMed ID: 25456130
[TBL] [Abstract][Full Text] [Related]
20. Intracellular signaling pathways activated by kisspeptins through GPR54: do multiple signals underlie function diversity?
Castaño JP; Martínez-Fuentes AJ; Gutiérrez-Pascual E; Vaudry H; Tena-Sempere M; Malagón MM
Peptides; 2009 Jan; 30(1):10-5. PubMed ID: 18775460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
